Found: 5
Select item for more details and to access through your institution.
Soluble TREM2 is elevated in Parkinson's disease subgroups with increased CSF tau.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Diagnostic and Prognostic Performance of the Modified Lumipulse pTau 181 Assay in Plasma for Alzheimer's Disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.060879
- By:
- Publication type:
- Article
CSF Biomarkers of Amyloid and Tau Pathologies in Participants Enrolled in the Stanford Alzheimer's Disease Research Center.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 5, p. 1, doi. 10.1002/alz.068261
- By:
- Publication type:
- Article
Plasma Biomarkers of Tau and Neurodegeneration During Major Cardiac and Noncardiac Surgery.
- Published in:
- JAMA Neurology, 2021, v. 78, n. 11, p. 1407, doi. 10.1001/jamaneurol.2021.2823
- By:
- Publication type:
- Article
Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01116-2
- By:
- Publication type:
- Article